Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleMetabolism, Transport, and Pharmacogenomics

Delineating the role of various factors in renal disposition of digoxin through application of physiologically-based kidney model to renal impairment populations

Daniel Scotcher, Christopher R. Jones, Aleksandra Galetin and Amin Rostami-Hodjegan
Journal of Pharmacology and Experimental Therapeutics January 5, 2017, jpet.116.237438; DOI: https://doi.org/10.1124/jpet.116.237438
Daniel Scotcher
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher R. Jones
2 AstraZeneca
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Galetin
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amin Rostami-Hodjegan
1 University of Manchester;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

jpet.116.237438
DOI 
https://doi.org/10.1124/jpet.116.237438
PubMed 
28057840

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online January 5, 2017.

Article Versions

  • You are currently viewing an Earlier version of this article (January 5, 2017 - 13:48).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Daniel Scotcher1,
  2. Christopher R. Jones2,
  3. Aleksandra Galetin1, and
  4. Amin Rostami-Hodjegan1,*
  1. 1 University of Manchester;
  2. 2 AstraZeneca
  1. ↵*Address correspondence to: amin.rostami{at}manchester.ac.uk

Statistics from Altmetric.com

Article usage

Article usage: January 2017 to February 2023

AbstractFullPdf
Jan 20172350127
Feb 201782193109
Mar 20171810371
Apr 2017155846
May 2017144831
Jun 2017104229
Jul 201744039
Aug 201724634
Sep 201753917
Oct 201714328
Nov 2017123531
Dec 201724017
Jan 201843211
Feb 201812416
Mar 201843219
Apr 201823923
May 201822827
Jun 201823316
Jul 201812415
Aug 201802410
Sep 20180228
Oct 20180279
Nov 201816915
Dec 201822218
Jan 201933424
Feb 201912021
Mar 2019151923
Apr 201923244
May 201902331
Jun 201941915
Jul 201913711
Aug 201902214
Sep 201914322
Oct 201902616
Nov 201924523
Dec 201923218
Jan 202003718
Feb 202005134
Mar 202014425
Apr 202014118
May 202004339
Jun 202003124
Jul 202023126
Aug 202016022
Sep 202012315
Oct 202032315
Nov 202033426
Dec 202023017
Jan 202144039
Feb 2021103726
Mar 202175140
Apr 202152223
May 2021112520
Jun 2021154025
Jul 202162222
Aug 202183730
Sep 202152323
Oct 202142924
Nov 202124134
Dec 202123320
Jan 202214352
Feb 202252624
Mar 2022612824
Apr 202265035
May 2022103436
Jun 202294021
Jul 202233117
Aug 202263836
Sep 202283942
Oct 202254325
Nov 2022113319
Dec 202252219
Jan 2023103529
Feb 20232195

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 384 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 384, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Delineating the role of various factors in renal disposition of digoxin through application of physiologically-based kidney model to renal impairment populations
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleMetabolism, Transport, and Pharmacogenomics

Delineating the role of various factors in renal disposition of digoxin through application of physiologically-based kidney model to renal impairment populations

Daniel Scotcher, Christopher R. Jones, Aleksandra Galetin and Amin Rostami-Hodjegan
Journal of Pharmacology and Experimental Therapeutics January 5, 2017, jpet.116.237438; DOI: https://doi.org/10.1124/jpet.116.237438

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleMetabolism, Transport, and Pharmacogenomics

Delineating the role of various factors in renal disposition of digoxin through application of physiologically-based kidney model to renal impairment populations

Daniel Scotcher, Christopher R. Jones, Aleksandra Galetin and Amin Rostami-Hodjegan
Journal of Pharmacology and Experimental Therapeutics January 5, 2017, jpet.116.237438; DOI: https://doi.org/10.1124/jpet.116.237438
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • HDL Mimetic 4F Modulates Aβ Distribution in Brain and Plasma
  • AOX1 Inhibition by Gefitinib, Erlotinib, and Metabolites
  • Catalytic Activity of CYP2C9 Variants
Show more Metabolism, Transport, and Pharmacogenomics

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics